OIA Maintains ISO 13485 (Medical Devices) Certification with Zero Non-Conformances

We are thrilled to share some exciting news with all of you! Following a rigorous surveillance audit conducted by our certification body, NQA, last week, Oxford Immune Algorithmics is delighted to announce that we have successfully maintained our ISO 13485 certification. Even more remarkable is the fact that, once again, we have achieved this milestone without any non-conformances. This accomplishment is a testament to our entire team's dedication and hard work, particularly those who have been instrumental in our ISO 13485 Audit Prep Team.

Our Commitment to Excellence

At Oxford Immune Algorithmics, our commitment to maintaining the highest quality standards in developing and delivering innovative healthcare solutions is unwavering. The ISO 13485 certification is an internationally recognized standard that sets out the requirements for a quality management system specifically designed for medical device manufacturers. It demonstrates our commitment to consistently meeting customer and regulatory requirements while continuously improving our processes.


A Year of Dedication


While times have not always been busy going through difficult market times, maintaining an ISO 13485 certification is no small feat and requires a collective effort from every member of our organization. Over the past year, our team has demonstrated exceptional dedication and professionalism in upholding the standard's stringent requirements. We have ensured that our quality management system remains robust, effective, and compliant through meticulous documentation, regular audits, and continuous improvement initiatives.

We want to extend a heartfelt thanks to everyone who has played a crucial role in this achievement, with a special mention to our ISO 13485 Audit Prep Team members. Your hard work, attention to detail, and tireless commitment to excellence have been instrumental in maintaining our certification with zero non-conformances. Your efforts have not gone unnoticed, and we are immensely grateful for your contributions.

Moving Forward

While we celebrate this significant milestone, we must also remember that maintaining excellence is an ongoing process. We will continue to invest in our quality management system, ensuring it remains aligned with our industry's evolving needs and stakeholders' expectations. Regular internal audits, thorough training programs, and proactive measures will remain integral to our quality culture.

Maintaining our ISO 13485 certification with no non-conformances is an accomplishment reflecting our entire team's dedication and hard work. We are immensely proud of this achievement and grateful to everyone who has contributed to its success.

Our commitment to delivering safe, reliable, and effective medical devices remains steadfast, and we will strive for excellence in all operations. Thank you, everyone, in our teams, for your unwavering support and dedication to our shared mission at Oxford Immune Algorithmics

About Oxford Immune Algorithmics

Incubated by the University of Oxford, OIA is a deep-tech start-up that aims to responsibly apply Artificial General Intelligence (AGI), Algocyte
®, to eradicate all preventable diseases by enabling predictive, precise, and personalised medicine to everyone.

Previous
Previous

Michelle Lea, experienced senior healthcare executive, appointed CEO at Oxford Immune Algorithmics

Next
Next

OIA Welcomes New Strategic Investor Mark Stevenson, & New Board Advisor, Abel Archundia, to Drive Growth & Innovation in AI-Powered Precision Medicine